Loss of X Chromosome May Reduce Chances Of Natural Pregnancy – Asian Scientist Magazine
Researchers have identified a link between the loss of the X chromosome (LOX) in white blood cells and a decreased likelihood of natural conception. A study published in Reproductive BioMedicine Online found that women experiencing infertility had higher proportions of LOX cells compared to those who conceived naturally, suggesting this genetic factor may represent a previously overlooked dimension of reproductive aging.
While men can lose the Y chromosome as they age—a process linked to conditions like heart disease and diabetes—women may lose one of their X chromosomes. This process, known as LOX, has now been identified as a potential factor in female reproductive health.
The Association Between LOX and Fertility
In a study of 504 women aged 20 to 45, researchers at Osaka Metropolitan University compared LOX levels in 123 women who conceived naturally and 381 women who had not. Using a highly sensitive single-cell genetic test, the team discovered that when the proportion of cells showing X chromosome loss exceeded approximately 0.9%, the chances of natural conception declined. The scientists identified a specific threshold of 0.87% LOX that correlates with a reduced likelihood of natural pregnancy.
Samantha Carter notes that while established markers like the anti-Müllerian hormone (AMH) assess ovarian reserve, this study indicates that LOX functions independently of traditional fertility markers. This suggests that physicians may eventually use a combination of tests to gain a more comprehensive view of an individual’s reproductive potential.
Why This Research Matters
Current clinical practice relies heavily on markers such as AMH and follicle-stimulating hormone (FSH) to assess fertility. However, the study found no association between LOX and these conventional markers, implying that LOX reflects a different aspect of biological aging. Taiki Kikuchi, the first author of the study from the Department of Obstetrics and Gynaecology at Osaka Metropolitan University, stated that combining AMH with LOX analysis could enable more accurate predictions regarding the possibility of natural pregnancy.
Future Clinical Implications
As researchers continue to explore this connection, measuring LOX could eventually help clinicians determine whether to initiate fertility treatments, such as in vitro fertilisation, at an earlier stage. Because previous research relied on older methods that could only detect high levels of chromosomal mosaicism, this newer, more sensitive technique allows for the identification of much lower levels of LOX that were previously missed. Further research remains necessary to follow women over time and examine reproductive tissues directly before LOX can be established as a standard clinical biomarker.
Frequently Asked Questions
What is the primary finding of the study regarding LOX?
Researchers found that women struggling with infertility had a significantly higher proportion of white blood cells lacking an X chromosome compared to those who conceived naturally.
Does LOX correlate with current fertility markers like AMH or FSH?
No. The study found no association between LOX and AMH or FSH, suggesting that LOX provides information about reproductive aging that is distinct from conventional tests.
Can LOX be used as a diagnostic tool right now?
Not yet. The scientists noted that more research is required, including longitudinal studies that follow women over time, before LOX can be officially used as a clinical biomarker.
How do you think new genetic insights into reproductive health might change the way couples approach family planning in the future?